Company Filing History:
Years Active: 2014-2018
Title: Innovations by Inventor Sirpa Jylhä
Introduction: Sirpa Jylhä is a notable inventor based in Espoo, Finland, known for her contributions to the field of immunology through her innovative patent work. With three patents to her name, Jylhä focuses on developing hypoallergenic solutions to combat allergic reactions, particularly against birch pollen.
Latest Patents: Among her latest patents is the invention of mutant polypeptides that serve as hypoallergens. This invention specifically includes mutant Bet v 1 proteins that can be utilized as hypoallergens for desensitization treatments against birch pollen allergies. Additionally, her work encompasses vaccine formulations that utilize these polypeptides, along with methods of vaccination to prevent birch pollen allergy.
Another significant patent involves allergen-binding IgE monoclonal antibodies and the methods for preparing hypoallergens. This invention relates to human IgE antibodies that can bind to non-continuous planar allergenic epitopes, such as in β-lactoglobulin, showcasing high affinity and specificity. Jylhä's patent also covers the processes for creating and engineering these antibodies, with applications in immunodiagnostics and immunotherapy.
Career Highlights: Jylhä has had an impactful career working with prominent organizations such as Desentum and VTT Technical Research Centre of Finland. Her experiences at these institutions have significantly influenced her research and patent development, enabling her to address pressing health issues associated with allergies.
Collaborations: Throughout her career, Jylhä has collaborated with esteemed colleagues, including Kristiina Takkinen and Marja-Leena Laukkanen. These collaborations have fostered a dynamic research environment, enhancing the innovation process leading to her patented inventions.
Conclusion: Sirpa Jylhä is a distinguished inventor whose work in hypoallergenic advancements is vital for improving the quality of life for individuals suffering from allergies. Her patents not only showcase her innovative thinking but also highlight her commitment to addressing health challenges through science and technology. With continued research and collaboration, her contributions in the field of immunology promise to lead to significant breakthroughs.